| NCT Number | NCT04823663 |
| Lead Sponsor | Boston Scientific Corporation |
| Conditions | Cardiac Disease |
| Enrollment | 12,500 participants |
| Start Date | 2021-03-31 |
| Primary Completion | 2030-12-31 (estimated) |
| Study Completion | 2030-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-24 |